0,869  0,003  Caspase 3 stimulant
0,817  0,015  Apoptosis agonist
0,747  0,005  NOS2 expression inhibitor
0,721  0,003  Melanin inhibitor
0,732  0,016  Antineoplastic (breast cancer)
0,723  0,011  Antileukemic
0,706  0,004  Skin whitener
0,707  0,023  Caspase 9 stimulant
0,654  0,008  Antioxidant
0,655  0,011  Chemopreventive
0,638  0,006  Antineoplastic (glioma)
0,633  0,009  Antiosteoporotic
0,617  0,005  Antineoplastic (glioblastoma multiforme)
0,601  0,014  Bone diseases treatment
0,596  0,012  Proliferative diseases treatment
0,601  0,031  Transcription factor NF kappa B inhibitor
0,589  0,024  Antineoplastic (colorectal cancer)
0,572  0,010  Antiprotozoal (Leishmania)
0,583  0,024  Antineoplastic (colon cancer)
0,570  0,023  Aldehyde oxidase inhibitor
0,562  0,019  Antineoplastic (ovarian cancer)
0,521  0,014  Nitric oxide antagonist
0,566  0,063  Antiinflammatory
0,523  0,024  Antihypercholesterolemic
0,516  0,018  NOS3 expression inhibitor
0,506  0,012  Antimitotic
0,509  0,015  Free radical scavenger
0,495  0,004  Estrogen agonist
0,494  0,003  Estrogen receptor beta agonist
0,528  0,040  Antineoplastic (lung cancer)
0,515  0,029  Prostate cancer treatment
0,485  0,011  Antimutagenic
0,485  0,014  Antineoplastic (lymphoma)
0,472  0,005  Protein-tyrosine phosphatase 1B inhibitor
0,491  0,023  Cardioprotectant
0,470  0,004  Estrogen receptor beta antagonist
0,491  0,026  CYP2C19 inhibitor
0,467  0,004  Estrogen antagonist
0,507  0,045  TNF expression inhibitor
0,467  0,005  Protein-tyrosine phosphatase inhibitor
0,482  0,022  UGT1A9 substrate
0,477  0,046  15-Lipoxygenase inhibitor
0,423  0,004  Cystathionine beta-synthase inhibitor
0,453  0,036  Ulceration
0,433  0,022  Antipyretic
0,430  0,020  UGT1A6 substrate
0,432  0,032  AR expression inhibitor
0,424  0,025  UGT2B4 substrate
0,426  0,030  ICAM1 expression inhibitor
0,404  0,010  Genotoxic
0,399  0,010  VCAM1 expression inhibitor
0,409  0,027  Antiamyloidogenic
0,410  0,029  CYP1A2 inhibitor
0,389  0,009  NOS3 expression enhancer
0,386  0,014  GST M1-1 substrate
0,373  0,005  Alpha 2c adrenoreceptor antagonist
0,398  0,030  Cardiovascular analeptic
0,374  0,010  UGT2B15 substrate
0,393  0,029  Hypoglycemic
0,367  0,005  Alpha 2a adrenoreceptor antagonist
0,380  0,023  UDP-glucuronosyltransferase substrate
0,360  0,004  Postmenopausal disorders treatment
0,402  0,045  5 Hydroxytryptamine release stimulant
0,373  0,024  Antineoplastic (lymphocytic leukemia)
0,416  0,067  Histamine release inhibitor
0,360  0,012  Topoisomerase II inhibitor
0,355  0,008  Renal failure treatment
0,359  0,014  UGT1A3 substrate
0,390  0,046  Respiratory analeptic
0,365  0,022  5 Hydroxytryptamine uptake stimulant
0,383  0,040  CTGF expression inhibitor
0,354  0,013  Amylase inhibitor
0,382  0,042  Lipoxygenase inhibitor
0,353  0,015  MAO inhibitor
0,342  0,004  Electron transport complex I inhibitor
0,378  0,045  Antineoplastic (brain cancer)
0,352  0,023  UGT1A1 substrate
0,333  0,007  Alpha 2 adrenoreceptor antagonist
0,368  0,048  Antineoplastic (melanoma)
0,388  0,068  Immunosuppressant
0,385  0,067  CYP3A4 substrate
0,396  0,079  Antibacterial
0,322  0,007  Nitric-oxide synthase stimulant
0,333  0,022  Hepatoprotectant
0,383  0,074  Antipruritic, allergic
0,347  0,045  Chemoprotective
0,345  0,046  Hypoxia-inducible factor 1 alpha inhibitor
0,342  0,045  Sensitization
0,309  0,012  MAO B inhibitor
0,307  0,013  Glutathione S-transferase substrate
0,345  0,052  CYP2C19 substrate
0,314  0,020  Pneumotoxic
0,381  0,091  5 Hydroxytryptamine release inhibitor
0,305  0,017  Monophenol monooxygenase inhibitor
0,333  0,045  Antineoplastic (small cell lung cancer)
0,313  0,026  Antihypotensive
0,327  0,044  Tumour necrosis factor alpha release inhibitor
0,342  0,063  Antifungal
0,290  0,012  Succinate dehydrogenase inhibitor
0,337  0,062  Apoptosis antagonist
0,390  0,119  Alpha-glucosidase inhibitor
0,330  0,059  Analeptic
0,273  0,003  Neuraminidase inhibitor
0,345  0,076  Vasodilator, peripheral
0,281  0,013  UGT2B9 substrate
0,304  0,040  Antineoplastic (sarcoma)
0,276  0,012  LDLR expression enhancer
0,301  0,038  Antihypertriglyceridemic
0,326  0,069  Vasodilator, coronary
0,285  0,030  UGT2B7 substrate
0,325  0,070  Hepatic disorders treatment
0,315  0,062  CYP1A2 substrate
0,256  0,006  Estrogen receptor alpha antagonist
0,366  0,116  Alzheimer's disease treatment
0,321  0,071  CYP2D6 substrate
0,318  0,070  12-Lipoxygenase inhibitor
0,270  0,029  Prostatic (benign) hyperplasia treatment
0,293  0,052  Cytotoxic
0,274  0,035  UGT1A4 substrate
0,253  0,017  Carcinogenic, group 1
0,251  0,015  SULT1A3 substrate
0,286  0,055  Cytostatic
0,290  0,060  Antineoplastic (cervical cancer)
0,261  0,031  Antipruritic, non-allergic
0,278  0,050  Amyloid beta aggregation inhibitor
0,247  0,022  Heat shock protein 90 antagonist
0,266  0,044  Peroxidase inhibitor
0,282  0,060  Antineoplastic (renal cancer)
0,228  0,012  Topoisomerase II alpha inhibitor
0,227  0,011  Beta amyloid protein antagonist
0,274  0,058  Vasodilator
0,259  0,043  Antiviral (Influenza)
0,297  0,082  Sodium/bile acid cotransporter inhibitor
0,241  0,029  Lipid peroxidase inhibitor
0,227  0,016  Antihemorrhagic
0,254  0,043  Antihelmintic
0,237  0,028  Tubulin antagonist
0,309  0,101  CYP2C9 substrate
0,227  0,020  Topoisomerase I inhibitor
0,207  0,004  Neuraminidase (influenza) inhibitor
0,266  0,066  Vascular (periferal) disease treatment
0,225  0,026  Cyclooxygenase 1 inhibitor
0,253  0,059  Antiparasitic
0,237  0,044  CYP2B6 inhibitor
0,240  0,051  Abortion inducer
0,188  0,005  Estrogen receptor alpha agonist
0,194  0,012  Antineoplastic (uterine cancer)
0,194  0,014  Gastritis treatment
0,208  0,032  UGT2B10 substrate
0,321  0,145  Antidiabetic
0,321  0,145  Cyclophilin D inhibitor
0,206  0,031  Acetylcholinesterase inhibitor
0,259  0,087  Spasmolytic
0,181  0,010  Macrophage migration inhibitory factor inhibitor
0,287  0,117  GST A substrate
0,256  0,087  Lipoprotein disorders treatment
0,179  0,012  NAD(P)H dehydrogenase (quinone) inhibitor
0,193  0,029  Alpha adrenoreceptor antagonist
0,183  0,019  UGT2B1 substrate
0,181  0,018  Opioid antagonist
0,221  0,058  Neurotrophic factor enhancer
0,216  0,055  P-glycoprotein inhibitor
0,240  0,081  Superoxide dismutase inhibitor
0,191  0,032  Psychosexual dysfunction treatment
0,206  0,048  VEGF expression inhibitor
0,199  0,042  Protein kinase stimulant
0,198  0,044  Toxic, respiratory center
0,171  0,018  Beta glucuronidase inhibitor
0,161  0,008  Leukotriene synthesis inhibitor
0,282  0,129  GABA C receptor rho-3 antagonist
0,168  0,017  Creatine kinase inhibitor
0,204  0,054  Diabetic nephropathy treatment
0,158  0,010  Antihypermotility
0,236  0,088  DNA damaging
0,225  0,077  Cyclic AMP phosphodiesterase inhibitor
0,293  0,147  Antiparkinsonian
0,168  0,025  Carbonic anhydrase XV inhibitor
0,188  0,046  Antineoplastic (squamous cell carcinoma)
0,231  0,089  Tyrosine 3 hydroxylase inhibitor
0,190  0,049  Antineoplastic (bone cancer)
0,144  0,006  Opioid kappa receptor agonist
0,266  0,129  Calcium channel activator
0,181  0,046  Antidiarrheal
0,185  0,052  Phobic disorders treatment
0,223  0,092  Antineoplastic (non-small cell lung cancer)
0,143  0,016  Keratolytic
0,160  0,033  Antiadrenergic
0,144  0,017  SULT1E1 substrate
0,158  0,033  Adrenaline antagonist
0,181  0,056  Cholinergic
0,141  0,016  Dopamine D1 antagonist
0,153  0,031  Papain-like protease (SARS coronavirus) inhibitor
0,176  0,053  Interferon gamma antagonist
0,177  0,057  Arachidonic acid antagonist
0,233  0,114  Antihypoxic
0,212  0,096  Antineoplastic (liver cancer)
0,264  0,148  CYP2C9 inhibitor
0,146  0,030  Carbonic anhydrase III inhibitor
0,181  0,066  Antirickettsial
0,193  0,078  Glyceraldehyde-3-phosphate dehydrogenase inhibitor
0,156  0,042  Cholesterol synthesis inhibitor
0,133  0,019  Alpha adrenoreceptor agonist
0,177  0,063  Antihelmintic (Nematodes)
0,246  0,132  FMO1 substrate
0,140  0,027  Prolactin inhibitor
0,138  0,026  Carcinogenic, group 2A
0,143  0,031  Sulfotransferase substrate
0,147  0,037  SULT1A1 substrate
0,154  0,045  Cyclooxygenase 3 inhibitor
0,148  0,038  Microtubule formation inhibitor
0,167  0,058  Cyclooxygenase inhibitor
0,144  0,036  Mucolytic
0,145  0,038  Contraceptive female
0,152  0,046  Aldehyde dehydrogenase inhibitor
0,162  0,056  CF transmembrane conductance regulator agonist
0,156  0,051  MAP kinase kinase 4 inhibitor
0,135  0,030  Toll-Like receptor 4 antagonist
0,149  0,045  Ca2+-transporting ATPase inhibitor
0,235  0,131  CYP3A4 inhibitor
0,168  0,065  Antiviral (Herpes)
0,104  0,003  Sodium/glucose cotransporter 2 inhibitor
0,128  0,028  UGT2B11 substrate
0,193  0,093  Antialcoholic
0,141  0,043  Alpha 2b adrenoreceptor antagonist
0,154  0,056  Antifungal enhancer
0,134  0,038  Antifungal (Pneumocystis)
0,110  0,015  Ca(v)3.1 blocker
0,104  0,009  Glutamate (mGluR7) antagonist
0,111  0,017  Leukotriene antagonist
0,114  0,020  Histone deacetylase stimulant
0,114  0,020  Histone deacetylase SIRT1 stimulant
0,211  0,119  Antineoplastic (pancreatic cancer)
0,098  0,006  Postcoital contraceptive
0,133  0,043  Expectorant
0,094  0,005  Leukotriene C antagonist
0,144  0,055  M18 aspartyl aminopeptidase inhibitor
0,162  0,074  Prostate disorders treatment
0,133  0,045  Constipation treatment
0,088  0,003  Sodium/glucose cotransporter inhibitor
0,204  0,119  Radioprotector
0,112  0,028  Histidine decarboxylase inhibitor
0,109  0,028  Opioid kappa receptor antagonist
0,121  0,042  Gastric antisecretory
0,102  0,026  Lipase inhibitor
0,127  0,053  Antiviral (Influenza B)
0,111  0,037  Actinic keratosis treatment
0,119  0,046  Urease inhibitor
0,147  0,074  Acaricide
0,243  0,170  Antiprotozoal
0,092  0,019  Alpha 1 adrenoreceptor agonist
0,094  0,023  Aromatase inhibitor
0,262  0,193  Calcium channel L-type activator
0,096  0,028  SULT1A2 substrate
0,085  0,017  Opioid agonist
0,148  0,080  Aldose reductase substrate
0,166  0,099  Antiarrhythmic
0,105  0,039  Ornithine decarboxylase inhibitor
0,145  0,080  GABA C receptor rho-2 antagonist
0,106  0,041  Acetylcholine M3 receptor agonist
0,186  0,121  Antidiabetic symptomatic
0,076  0,011  Kinesin-like protein 1 inhibitor
0,076  0,011  Kinesin antagonist
0,080  0,017  Transcription factor RelA inhibitor
0,157  0,094  Carcinogenic
0,085  0,022  3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor
0,099  0,038  Adrenaline agonist
0,099  0,038  Carbonic anhydrase XIII inhibitor
0,070  0,009  Nociceptin (N/OFQ) receptor antagonist
0,096  0,035  Na+ K+ transporting ATPase inhibitor
0,092  0,032  Narcotic antagonist
0,093  0,034  Estrogen-related receptor beta agonist
0,137  0,077  Mannose-6-phosphate isomerase inhibitor
0,184  0,125  RNA-directed DNA polymerase inhibitor
0,147  0,088  Mutagenic
0,063  0,004  Estrogen-related receptor beta antagonist
0,130  0,071  NADPH oxidase inhibitor
0,134  0,075  Farnesoid X receptor antagonist
0,097  0,040  Antiviral (Hepatitis A)
0,110  0,054  GST T1-1 substrate
0,110  0,056  5-Lipoxygenase inhibitor
0,111  0,057  MAO A inhibitor
0,085  0,032  Antitreponemal
0,159  0,107  Pyruvate kinase inhibitor
0,074  0,022  Alpha tubulin antagonist
0,140  0,088  Eye irritation, high
0,185  0,134  Antiprotozoal (Trypanosoma)
0,080  0,029  Beta tubulin antagonist
0,093  0,042  Antiprotozoal activity enhancer
0,199  0,150  Antineoplastic (multiple myeloma)
0,084  0,034  Dopamine agonist
0,090  0,040  Thioredoxin reductase inhibitor
0,120  0,072  DNA repair enzyme inhibitor
0,093  0,044  Carbonic anhydrase VI inhibitor
0,096  0,050  Androgen antagonist
0,080  0,034  Glucagon-like peptide 1 agonist
0,205  0,160  Cholesterol antagonist
0,135  0,091  Adenylate cyclase stimulant
0,133  0,090  Antidote
0,080  0,038  Glycine receptor agonist
0,154  0,112  Psychostimulant
0,062  0,020  Potassium channel Kv1.3 blocker
0,102  0,061  Chronic obstructive bronchitis treatment
0,097  0,056  Bile acid receptor antagonist
0,075  0,035  Dopamine D3 antagonist
0,148  0,107  Sedative
0,083  0,046  Dopamine antagonist
0,104  0,068  DOPA decarboxylase inhibitor
0,209  0,173  Antineoplastic (osteosarcoma)
0,087  0,052  Antineoplastic antibiotic
0,085  0,050  Alpha 1 adrenoreceptor antagonist
0,171  0,138  Myocardial infarction treatment
0,063  0,030  Thromboxane antagonist
0,103  0,070  Choleretic
0,075  0,042  Dopamine D2 antagonist
0,072  0,039  SULT2A1 substrate
0,050  0,018  Dopamine D5 agonist
0,147  0,117  Anesthetic general
0,103  0,073  GABA C receptor antagonist
0,156  0,126  Insulin sensitizer
0,093  0,063  Breast cancer-resistant protein inhibitor
0,067  0,038  Adrenaline uptake inhibitor
0,036  0,007  Sodium/glucose cotransporter 1 inhibitor
0,147  0,119  Cardiodepressant
0,064  0,037  Androgen agonist
0,189  0,162  Antimycobacterial
0,031  0,004  NMDA receptor phencyclidine site antagonist
0,041  0,014  Melatonin 1 agonist
0,041  0,015  ATM kinase inhibitor
0,074  0,048  Alpha 1a adrenoreceptor antagonist
0,084  0,058  D-Ala-D-Ala ligase inhibitor
0,046  0,023  Alpha 1L adrenoreceptor agonist
0,041  0,018  Glucocorticoid antagonist
0,092  0,069  Xanthine oxidase inhibitor
0,091  0,068  Alpha 2d adrenoreceptor antagonist
0,103  0,081  Antitussive
0,183  0,162  Antidepressant
0,086  0,065  GST P1-1 substrate
0,103  0,083  DNA polymerase I inhibitor
0,092  0,073  Carcinogenic, group 2B
0,112  0,094  Antibacterial (Helicobacter pylori)
0,054  0,036  Aldose reductase inhibitor
0,059  0,041  Ryanodine receptor antagonist
0,052  0,034  Glucose-6-phosphate translocase inhibitor
0,116  0,099  Antineoplastic (carcinoma)
0,098  0,081  Multidrug resistance-associated protein 1 inhibitor
0,069  0,052  Secretase beta inhibitor
0,035  0,018  Nucleoside transporters inhibitor
0,042  0,025  Dopamine D3 agonist
0,102  0,085  Photosensitizer
0,048  0,033  Mineralocorticoid receptor antagonist
0,081  0,066  mTOR complex 2 inhibitor
0,038  0,023  Progesterone antagonist
0,080  0,066  Antineoplastic alkaloid
0,083  0,069  NADH dehydrogenase inhibitor
0,025  0,013  Dopamine D1 agonist
0,059  0,047  Opioid delta receptor antagonist
0,082  0,071  Granulocyte macrophage colony stimulating factor agonist
0,090  0,080  Skin irritative effect
0,130  0,120  Heat shock protein 70 antagonist
0,137  0,128  Embryotoxic
0,032  0,023  Melatonin agonist
0,138  0,129  Teratogen
0,088  0,081  Anabolic
0,139  0,132  Phospholipase C inhibitor
0,050  0,044  Alpha-mannosidase inhibitor
0,039  0,034  Cholesterol absorption inhibitor
0,060  0,054  Opioid mu receptor antagonist
0,103  0,099  Toll-Like receptor 2 antagonist
0,130  0,126  Tumour necrosis factor antagonist
0,019  0,016  Imidazoline I1 receptor antagonist
0,021  0,019  Dopamine autoreceptor agonist
0,055  0,053  HIV-1 integrase (3'-Processing) inhibitor
0,038  0,036  Dopamine D2 agonist

